Clinical Trials and Research

At the core of what we do is make sure that we give you the best chance for the best outcome. That means pushing the scientific boundaries of our cancer knowledge and leaving no stone unturned when it comes to new and innovative therapies.

Researcher at the Center for Cancer Research.

Making Progress Every Single Day

Last year, more than 4,500 people participated in clinical trials at the Cancer Center, leading to new knowledge and breakthrough therapies. Our clinical trials offer access to tomorrow's therapies today.

Search our clinical trials listings

Center for Cancer Research

The Center for Cancer Research serves as the scientific engine for discovery for the Mass General Cancer Center.

Immunotherapy

The Mass General Cancer Center is committed to understanding the mechanisms by which the immune system works to kill cancer.

Visit the Cancer Outcomes Research and Education Program website.

Cancer Outcomes Research & Education Program

The CORE program conducts innovative research and educational programs to improve the experience and outcomes of patients and caregivers across the continuum of cancer care.

Videos

Dr. Rebecca Heist, Medical Oncologist, and Casandra McIntyre, Nurse Director of the Termeer Center for Targeted Therapies, briefly discuss what clinical trials are and why they are important. Learn how clinical trials are benefitting patients and how we are keeping enrollees safe.

Go behind the scenes with our Director of Clinical Research, Dr. Keith Flaherty to learn how teams of researchers and clinicians are applying scientific insights to propel the creation of new therapies for patients, and get to know more about what motivates him to do what he does every day.

Learn about clinical trials in this video with Elizabeth Abraham, RN, clinical research nurse at Mass General Cancer Center. Elizabeth describes what is involved with clinical trials in order to help improve your understanding so you can better navigate the process of being enrolled in a trial.

1 of 3

Progress in Targeted Cancer Care

Eradicating cancer takes commitment and creativity. We have both. Commitment to explore novel combinations of therapies. Creativity to collaborate, apply learnings, and advance treatment options.

Henri and Belinda Termeer Center for Targeted Therapies

The Termeer Center offers a comprehensive translational research program to speed the discovery and delivery of new targeted therapies to patients with early and advanced stage cancers.

Learn more

Henri and Belinda Termeer Center for Targeted Therapies sign in Yawkey building.

1 of 1

Progress in Immunotherapy

The Mass General Cancer is proud to be an authorized treatment center for FDA approved CAR T-cell therapies for adult patients with lymphoma and for adult patients with multiple myeloma. Where, before, patients were given little or no hope, now there is real and meaningful scientific progress. Today it's CAR-T therapy. Tomorrow? We think big so you can dream big.

Learn more

Noopur Raje, MD, Marcela Maus, MD, PhD and Matthew Frigault, MD discuss the power and evolution of immune therapies, specifically, CAR T-Cell therapy in treating cancer.

1 of 1

Progress in Early Cancer Detection

Cancer Early Detection

The Cancer Early Detection and Diagnostics Clinic is a multidisciplinary collaboration working to bridge the gap between clinical care and research in cancer early detection.

Learn more

Lecia V. Sequist, MD, MPH and Ibiayi Dagogo-Jack, MD.

1 of 1

Browse Cancer Center Research Labs

Browse Research Areas

Basic Research: Cellular Immunotherapy Program | Center for Cancer Immunology | Center for Cancer Research

Clinical Resources: Biomarker Discovery Lab | Center for Cancer Risk Assessment | Immune Monitoring Laboratory | Tumor Imaging Metrics Core

Research Funding

American Cancer Society Institutional Research Grant